A field portable method for the semi-quantitative estimation of dehydration tolerance of photosynthetic tissues across distantly related land plants.

Preprint sustituido por postprint 9-12-2019Desiccation tolerant (DT) plants withstand complete cellular dehydration (reaching relative water contents below 30% in their photosynthetic tissues), while desiccation sensitive (DS) plants exhibit different degrees of dehydration tolerance (DHT), never surviving water loss >70%. To date, no procedure for the quantitative evaluation of DHT extent exists that is able to discriminate DS species with different degrees of DHT from truly DT plants. We developed a simple, feasible, and portable protocol to differentiate between constitutive DT and different degrees of DHT in photosynthetic tissues. The protocol is based on (i) controlled desiccation inside Falcon tubes equilibrated at three different relative humidities (RH: 80%, 50% and <10%) and (ii) evaluation of the average recovery level of maximal photochemical efficiency (Fv/Fm) after rehydration. Applying the method to 10 bryophytes and 28 tracheophytes from various locations, we found that (i) imbibition of absorbent material with saturated salt solutions inside the tubes provides stable RH and avoids direct contact with samples; (ii) for 50 mL capacity tubes, the optimal initial plant amount is 50–200 mg FW; (iii) the tubes can be re-used up to three times with very little changes in RH; (iv) the method is useful in remote locations due to minimal instrumental requirements; (v) a threshold of 30% recovery of the initial Fv/Fm correctly categorises DT species with a few exceptions among tracheophytes: poikilochorophyllous DT-species and some DS herbs and gymnosperms. The protocol provides a semi-quantitative expression of DHT that facilitates comparisons of species with different morpho-physiological traits and/or ecological attributes.Basque Government (UPV/EHU IT-1018-16); Spanish Ministry of Economy and Competitiveness (MINECO) and the ERDF (FEDER) (CTM2014-53902-C2-2-P to JIGP and BFM, CGL2014-54127-P to ENO and JMA, and CTM2014-53902-C2-1-P to JF and JG); Juan de la Cierva-Incorporation fellowship IJCI-2014-22489 to BFM and Juan de la Cierva-Formación FPDI-2013-18167 and FPDI-2013-17135 to MJCM and JoG respectively); MC was supported by a predoctoral fellowship FPI/1700/2014 from the Conselleria d’Educació, Cultura i Universitats (Govern de les Illes Balears) and ESF; MN was supported by a predoctoral fellowship BES-2015-072578 from the Spanish Ministry of Economy and Competitiveness (MINECO) co-financed by the ESF. APC was supported by Spanish Ministry of Education, Culture and Sport (MECD) fellowship (FPU15/02054). MLP was supported by a pre-doctoral grant from the Basque Government. Authors also wish to thank for giving access to the living plant collection of the Royal Botanic Garden Edinburgh. Jill M. Farrant acknowledges funding from the South African Department of Science and Technology and National Research Foundation (grant number 98406

Innovative procurement theories to optimise educational outcomes per total cost of school facilities : Research project report [of the] ARC Value in Operations

This study aimed to develop a Value Rating Tool to assess value for money in infrastructure assets.The key finding from this study is as follows:• This study developed a fully implementable Value Rating Tool, which can be used to observe the school’s built environment contribution to educational outcomes and their whole-life cost. The Value Rating Tool is the most comprehensive post-completion review and benchmarking tool, as far as the research team are aware.The Value Rating Tool was developed in school setting. The Value Rating Tool can be applied to primary and secondary schools including schools incorporating trends in delivery e.g., vertical schools and modular school buildings

Physical activity in the androgen receptor knockout mouse: Evidence for reversal of androgen deficiency on cancellous bone

Disruption of the androgen receptor (AR) in male mice reduces cortical bone expansion and muscle mass during puberty and results in high bone turnover-related cancellous osteopenia. We hypothesized that voluntary wheel running during growth is able to rescue the effects of AR disruption on bone. To this end, 5-week-old AR knockout (ARKO) mice were randomized to a running group (cage with running wheel) and a sedentary group (cage without wheel) and followed-up until 16 weeks of age. Voluntary wheel running in ARKO mice did not influence body weight, muscle mass or periosteal bone expansion. Interestingly, Voluntary running significantly reduced bone turnover in ARKO mice and prevented cancellous bone loss due to a preservation of trabecular number. Thus, voluntary running in ARKO mice was able to reduce cancellous bone resorption, suggesting that sustained exercise may potentially compensate the effects of androgen disruption on cancellous bone. (C) 2008 Elsevier Inc. All rights reservedstatus: publishe

Oxidative stress, inflammation and treatment response in major depression

OBJECTIVE: Increased inflammation and oxidative stress have been shown in Major Depressive Disorder (MDD), although there is significant heterogeneity across studies. Whether markers of inflammation and oxidative stress are associated with antidepressant treatment response in MDD is currently unclear. The goals of the present study are to investigate markers of inflammation and oxidative stress in unmedicated MDD subjects and controls and test the relationship between these markers and antidepressant response in MDD subjects.METHODS: Interleukin (IL)-6, tumor necrosis factor (TNF)-α, C-reactive protein, F2-isoprostanes, 8-OH 2-deoxyguanosine (8-OHdG), glutathione peroxidase, glutathione, and vitamin C were quantified in blood samples from 50 unmedicated MDD subjects and 55 healthy controls. Depression symptom severity was rated with the 17-item Hamilton Depression Rating Scale (HDRS). All subjects were somatically healthy and free from medications that could interfere with inflammation and oxidative stress markers. A subgroup of 22 MDD subjects underwent open-label selective serotonin reuptake inhibitor (SSRI) antidepressant treatment for eight weeks, after which blood sampling and the HDRS were repeated. Antidepressant treatment "response" was defined as ≥50% decrease in HDRS ratings over 8 weeks of treatment.RESULTS: After controlling for the effects of age, sex, body mass index and smoking, MDD subjects had significantly higher levels of IL-6 (p<0.001), TNF-α (p<0.001), 8-OHdG (p=0.018), and F2-isoprostanes (p=0.012). Compared to Responders, Non-responders to SSRI antidepressant treatment had higher levels of F2-isoprostanes at baseline (p=0.006), and after eight weeks of treatment (p=0.031). Non-responders showed a significant increase in 8-OHdG over the course of treatment (p=0.021), whereas Responders showed a significant decrease in IL-6 over the course of treatment (p=0.019).CONCLUSION: Our results are in line with previous reports of increased levels of markers of inflammation and oxidative stress in MDD. Moreover, poorer antidepressant treatment response was related to higher baseline levels of the major oxidative stress marker, F2-isoprostanes, in vivo. Further, antidepressant response was associated with changes in oxidative (8-OHdG) and inflammatory (IL-6) markers

Oxidative stress, inflammation and treatment response in major depression.

ObjectiveIncreased inflammation and oxidative stress have been shown in Major Depressive Disorder (MDD), although there is significant heterogeneity across studies. Whether markers of inflammation and oxidative stress are associated with antidepressant treatment response in MDD is currently unclear. The goals of the present study are to investigate markers of inflammation and oxidative stress in unmedicated MDD subjects and controls and test the relationship between these markers and antidepressant response in MDD subjects.MethodsInterleukin (IL)-6, tumor necrosis factor (TNF)-α, C-reactive protein, F2-isoprostanes, 8-OH 2-deoxyguanosine (8-OHdG), glutathione peroxidase, glutathione, and vitamin C were quantified in blood samples from 50 unmedicated MDD subjects and 55 healthy controls. Depression symptom severity was rated with the 17-item Hamilton Depression Rating Scale (HDRS). All subjects were somatically healthy and free from medications that could interfere with inflammation and oxidative stress markers. A subgroup of 22 MDD subjects underwent open-label selective serotonin reuptake inhibitor (SSRI) antidepressant treatment for eight weeks, after which blood sampling and the HDRS were repeated. Antidepressant treatment "response" was defined as ≥50% decrease in HDRS ratings over 8 weeks of treatment.ResultsAfter controlling for the effects of age, sex, body mass index and smoking, MDD subjects had significantly higher levels of IL-6 (p&lt;0.001), TNF-α (p&lt;0.001), 8-OHdG (p=0.018), and F2-isoprostanes (p=0.012). Compared to Responders, Non-responders to SSRI antidepressant treatment had higher levels of F2-isoprostanes at baseline (p=0.006), and after eight weeks of treatment (p=0.031). Non-responders showed a significant increase in 8-OHdG over the course of treatment (p=0.021), whereas Responders showed a significant decrease in IL-6 over the course of treatment (p=0.019).ConclusionOur results are in line with previous reports of increased levels of markers of inflammation and oxidative stress in MDD. Moreover, poorer antidepressant treatment response was related to higher baseline levels of the major oxidative stress marker, F2-isoprostanes, in vivo. Further, antidepressant response was associated with changes in oxidative (8-OHdG) and inflammatory (IL-6) markers